24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients
Dirk J van Leeuwen, Leland J Yee, Rebecca G LangnerVolume:
97
Year:
2002
Language:
english
DOI:
10.1016/s0002-9270(01)04074-6
File:
PDF, 27 KB
english, 2002